1. Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
- Author
-
Churg A, Attanoos R, Borczuk AC, Chirieac LR, Galateau-Sallé F, Gibbs A, Henderson D, Roggli V, Rusch V, Judge MJ, and Srigley JR
- Subjects
- Australasia, Canada, Europe, Evidence-Based Medicine methods, Evidence-Based Medicine standards, Evidence-Based Medicine statistics & numerical data, Guidelines as Topic standards, Humans, International Cooperation, Lung Neoplasms diagnosis, Mesothelioma diagnosis, Mesothelioma, Malignant, Pathologists, Pathology, Clinical methods, Pathology, Clinical statistics & numerical data, Societies, Medical, United Kingdom, United States, Lung Neoplasms therapy, Mesothelioma therapy, Pathology, Clinical standards, Peritoneum pathology, Pleura pathology, Research Report standards
- Abstract
Context: -The International Collaboration on Cancer Reporting is a not-for-profit organization formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom; the College of American Pathologists; the Canadian Association of Pathologists-Association Canadienne des Pathologists, in association with the Canadian Partnership Against Cancer; and the European Society of Pathology. Its goal is to produce common, internationally agreed upon, evidence-based datasets for use throughout the world., Objective: -To describe a dataset developed by the Expert Panel of the International Collaboration on Cancer Reporting for reporting malignant mesothelioma of both the pleura and peritoneum. The dataset is composed of "required" (mandatory) and "recommended" (nonmandatory) elements., Design: -Based on a review of the most recent evidence and supported by explanatory commentary., Results: -Eight required elements and 7 recommended elements were agreed upon by the Expert Panel to represent the essential information for reporting malignant mesothelioma of the pleura and peritoneum., Conclusions: -In time, the widespread use of an internationally agreed upon, structured, pathology dataset for mesothelioma will lead not only to improved patient management but also provide valuable data for research and international benchmarks.
- Published
- 2016
- Full Text
- View/download PDF